Documents
Application Sponsors
NDA 050661 | PHARMACIA AND UPJOHN | |
Marketing Status
Discontinued | 001 |
Discontinued | 002 |
Discontinued | 003 |
Application Products
001 | INJECTABLE;INJECTION | 10MG/VIAL | 0 | IDAMYCIN | IDARUBICIN HYDROCHLORIDE |
002 | INJECTABLE;INJECTION | 5MG/VIAL | 0 | IDAMYCIN | IDARUBICIN HYDROCHLORIDE |
003 | INJECTABLE;INJECTION | 20MG/VIAL | 0 | IDAMYCIN | IDARUBICIN HYDROCHLORIDE |
FDA Submissions
TYPE 1; Type 1 - New Molecular Entity | ORIG | 1 | AP | 1990-09-27 | PRIORITY |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 2 | AP | 1993-06-29 | PRIORITY |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 3 | AP | 1995-04-25 | PRIORITY |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 4 | AP | 1996-09-17 | PRIORITY |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 5 | AP | 1997-09-11 | PRIORITY |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 6 | AP | 1998-04-22 | PRIORITY |
LABELING; Labeling | SUPPL | 7 | AP | 2002-09-30 | STANDARD |
LABELING; Labeling | SUPPL | 8 | AP | 2002-10-11 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 9 | AP | 2000-04-07 | PRIORITY |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 10 | AP | 2000-11-21 | PRIORITY |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 11 | AP | 2002-04-02 | PRIORITY |
LABELING; Labeling | SUPPL | 14 | AP | 2014-12-04 | STANDARD |
LABELING; Labeling | SUPPL | 15 | AP | 2019-08-02 | STANDARD |
LABELING; Labeling | SUPPL | 16 | AP | 2021-02-10 | STANDARD |
LABELING; Labeling | SUPPL | 17 | AP | 2022-04-27 | STANDARD |
Submissions Property Types
ORIG | 1 | Orphan | 5 |
SUPPL | 2 | Null | 14 |
SUPPL | 3 | Null | 14 |
SUPPL | 4 | Null | 14 |
SUPPL | 5 | Null | 14 |
SUPPL | 6 | Null | 14 |
SUPPL | 9 | Null | 14 |
SUPPL | 10 | Null | 14 |
SUPPL | 11 | Null | 14 |
SUPPL | 14 | Null | 6 |
SUPPL | 15 | Null | 6 |
SUPPL | 16 | Null | 6 |
SUPPL | 17 | Null | 7 |
CDER Filings
PFIZER
cder:Array
(
[0] => Array
(
[ApplNo] => 50661
[companyName] => PFIZER
[docInserts] => ["",""]
[products] => [{"drugName":"IDAMYCIN","activeIngredients":"IDARUBICIN HYDROCHLORIDE","strength":"10MG\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"IDAMYCIN","activeIngredients":"IDARUBICIN HYDROCHLORIDE","strength":"5MG\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"IDAMYCIN","activeIngredients":"IDARUBICIN HYDROCHLORIDE","strength":"20MG\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
[labels] => [{"actionDate":"02\/10\/2021","submission":"SUPPL-16","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2021\\\/050661s016lbl.pdf\"}]","notes":""},{"actionDate":"08\/02\/2019","submission":"SUPPL-15","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/050661s015lbl.pdf\"}]","notes":""},{"actionDate":"12\/04\/2014","submission":"SUPPL-14","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/050661s014lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"IDAMYCIN","submission":"IDARUBICIN HYDROCHLORIDE","actionType":"10MG\/VIAL","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"IDAMYCIN","submission":"IDARUBICIN HYDROCHLORIDE","actionType":"5MG\/VIAL","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"IDAMYCIN","submission":"IDARUBICIN HYDROCHLORIDE","actionType":"20MG\/VIAL","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 2021-02-10
)
)